Iridex director Moore buys $14k in shares

Director William M. Moore of Iridex Corp (NASDAQ:IRIX), a micro-cap medical technology company valued at $19.63 million, recently purchased 12,024 shares of common stock. The shares were bought at a weighted average price of $1.1834, for a total transaction value of $14,229. The purchase comes as InvestingPro data shows the stock has declined over 11% in the past week, potentially presenting a buying opportunity according to Fair Value analysis.

The purchase, which occurred on August 18, 2025, was disclosed in a Form 4 filing with the Securities and Exchange Commission. The price paid for the shares ranged from $1.175 to $1.1899. Following the transaction, Moore directly owns 200,674 shares of Iridex.

Additionally, Moore indirectly owns 69,300 shares through his spouse and 30,026 shares through William M. Moore Trust & Patricia A. Moore Trust.

In other recent news, IRIDEX Corporation reported its second-quarter earnings for 2025, exceeding analysts’ expectations. The company achieved an earnings per share (EPS) of -$0.06, which was better than the anticipated -$0.09. Additionally, IRIDEX reported revenues of $13.6 million, surpassing the forecasted $13.1 million. These results indicate a positive performance for the company during this period. The earnings announcement has drawn attention from investors and analysts alike. While specific stock movements are not discussed, the earnings report highlights the company’s ability to outperform projections. Investors may look to firms like IRIDEX for further insights into their financial health and future prospects. These developments provide valuable information for those closely following the company’s financial performance.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.